Literature DB >> 26409849

Pathophysiology of Vascular Calcification.

Neal X Chen1, Sharon M Moe2,3,4.   

Abstract

Vascular calcification can lead to cardiovascular morbidity and mortality. The initiating factors and clinical consequences depend on the underlying disease state and location of the calcification. The pathogenesis of vascular calcification is complex and involves a transformation of vascular smooth muscle cells to an osteo/chondrocytic cell that expresses RUNX2 and produces matrix vesicles. The imbalance of promoters (such as hyperphosphatemia and hypercalcemia) and inhibitors (e.g., fetuin-A) is critical in the development of vascular calcification. The altered mineral metabolism and deficiency in inhibitors are common in patients with chronic kidney disease (CKD) and is one reason why vascular calcification is so prevalent in that population.

Entities:  

Keywords:  Calcification; Vascular calcification; Vascular smooth muscle cells

Mesh:

Substances:

Year:  2015        PMID: 26409849     DOI: 10.1007/s11914-015-0293-9

Source DB:  PubMed          Journal:  Curr Osteoporos Rep        ISSN: 1544-1873            Impact factor:   5.096


  108 in total

1.  Impact of vascular calcification on QT interval and QT dispersion in CKD and dialysis patients.

Authors:  Biagio Di Iorio; Antonio Bellasi
Journal:  Am J Nephrol       Date:  2012-02-29       Impact factor: 3.754

2.  The case against calcium-based phosphate binders.

Authors:  Sharon M Moe; Glenn M Chertow
Journal:  Clin J Am Soc Nephrol       Date:  2006-04-26       Impact factor: 8.237

Review 3.  Vascular calcification: pathophysiology and risk factors.

Authors:  Neal X Chen; Sharon M Moe
Journal:  Curr Hypertens Rep       Date:  2012-06       Impact factor: 5.369

4.  Elevated extracellular calcium levels induce smooth muscle cell matrix mineralization in vitro.

Authors:  Hsueh Yang; Gabrielle Curinga; Cecilia M Giachelli
Journal:  Kidney Int       Date:  2004-12       Impact factor: 10.612

5.  Upregulation of alkaline phosphatase and pyrophosphate hydrolysis: potential mechanism for uremic vascular calcification.

Authors:  K A Lomashvili; P Garg; S Narisawa; J L Millan; W C O'Neill
Journal:  Kidney Int       Date:  2008-02-20       Impact factor: 10.612

6.  Mutations in ENPP1 are associated with 'idiopathic' infantile arterial calcification.

Authors:  Frank Rutsch; Nico Ruf; Sucheta Vaingankar; Mohammad R Toliat; Anita Suk; Wolfgang Höhne; Galen Schauer; Mandy Lehmann; Tony Roscioli; Dirk Schnabel; Jörg T Epplen; Alex Knisely; Andrea Superti-Furga; James McGill; Marco Filippone; Alan R Sinaiko; Hillary Vallance; Bernd Hinrichs; Wendy Smith; Merry Ferre; Robert Terkeltaub; Peter Nürnberg
Journal:  Nat Genet       Date:  2003-08       Impact factor: 38.330

7.  Sodium-dependent phosphate cotransporters and phosphate-induced calcification of vascular smooth muscle cells: redundant roles for PiT-1 and PiT-2.

Authors:  Matthew H Crouthamel; Wei Ling Lau; Elizabeth M Leaf; Nicholas W Chavkin; Mary C Wallingford; Danielle F Peterson; Xianwu Li; Yonggang Liu; Michael T Chin; Moshe Levi; Cecilia M Giachelli
Journal:  Arterioscler Thromb Vasc Biol       Date:  2013-08-22       Impact factor: 8.311

8.  Dialysis accelerates medial vascular calcification in part by triggering smooth muscle cell apoptosis.

Authors:  Rukshana C Shroff; Rosamund McNair; Nichola Figg; Jeremy N Skepper; Leon Schurgers; Ashmeet Gupta; Melanie Hiorns; Ann E Donald; John Deanfield; Lesley Rees; Catherine M Shanahan
Journal:  Circulation       Date:  2008-10-06       Impact factor: 29.690

9.  Correlation of bone histology with parathyroid hormone, vitamin D3, and radiology in end-stage renal disease.

Authors:  A J Hutchison; R W Whitehouse; H F Boulton; J E Adams; E B Mawer; T J Freemont; R Gokal
Journal:  Kidney Int       Date:  1993-11       Impact factor: 10.612

10.  Bone morphogenetic protein-2 decreases microRNA-30b and microRNA-30c to promote vascular smooth muscle cell calcification.

Authors:  Joshua A F Balderman; Hae-Young Lee; Christopher E Mahoney; Diane E Handy; Kevin White; Sofia Annis; Djamel Lebeche; Roger J Hajjar; Joseph Loscalzo; Jane A Leopold
Journal:  J Am Heart Assoc       Date:  2012-12-19       Impact factor: 5.501

View more
  36 in total

Review 1.  Monckeberg's Medial Sclerosis as a Cause for Headache and Facial Pain.

Authors:  Davis C Thomas; Prisly Thomas; Anilkumar Sivan; Priyanka Unnam; Ahana Ajayakumar; Sanjana Santhosh Kumar; Priyanka Kodaganallur Pitchumani; Mahnaz Fatahzadeh; Nida-E-Haque Mahmud
Journal:  Curr Pain Headache Rep       Date:  2021-06-04

2.  SGK1 induces vascular smooth muscle cell calcification through NF-κB signaling.

Authors:  Jakob Voelkl; Trang Td Luong; Rashad Tuffaha; Katharina Musculus; Tilman Auer; Xiaoming Lian; Christoph Daniel; Daniel Zickler; Beate Boehme; Michael Sacherer; Bernhard Metzler; Dietmar Kuhl; Maik Gollasch; Kerstin Amann; Dominik N Müller; Burkert Pieske; Florian Lang; Ioana Alesutan
Journal:  J Clin Invest       Date:  2018-06-11       Impact factor: 14.808

Review 3.  Dolichoectasia of the internal carotid artery terminus, posterior communicating artery, and posterior cerebral artery: The embryonic caudal ramus internal carotid segmental vulnerability legacy.

Authors:  Chai Kobkitsuksakul; Kittiphop Somboonnitiphol; Mungkorn Apirakkan; Peerapong Lueangapapong; Ekachat Chanthanaphak
Journal:  Interv Neuroradiol       Date:  2019-08-22       Impact factor: 1.610

Review 4.  Alkaline phosphatase: a novel treatment target for cardiovascular disease in CKD.

Authors:  Mathias Haarhaus; Vincent Brandenburg; Kamyar Kalantar-Zadeh; Peter Stenvinkel; Per Magnusson
Journal:  Nat Rev Nephrol       Date:  2017-05-15       Impact factor: 28.314

5.  Matrix vesicles induce calcification of recipient vascular smooth muscle cells through multiple signaling pathways.

Authors:  Neal X Chen; Kalisha D O'Neill; Sharon M Moe
Journal:  Kidney Int       Date:  2017-10-09       Impact factor: 10.612

6.  Parathyroid hormone promotes osteoblastic differentiation of endothelial cells via the extracellular signal-regulated protein kinase 1/2 and nuclear factor-κB signaling pathways.

Authors:  Zhi-Yuan Cheng; Ting Ye; Qiu-Yang Ling; Ting Wu; Gang-Yong Wu; Gang-Jun Zong
Journal:  Exp Ther Med       Date:  2017-11-23       Impact factor: 2.447

7.  Adiponectin inhibits vascular smooth muscle cell calcification induced by beta-glycerophosphate through JAK2/STAT3 signaling pathway.

Authors:  Yan Lu; Yichao Ma; Ruihua Wang; Jing Sun; Beibei Guo; Ruipeng Wei; Yongping Jia
Journal:  J Biosci       Date:  2019-09       Impact factor: 1.826

Review 8.  Phosphate as a Signaling Molecule.

Authors:  Kittrawee Kritmetapak; Rajiv Kumar
Journal:  Calcif Tissue Int       Date:  2019-11-25       Impact factor: 4.333

9.  A biomarker for vascular calcification: shedding light on an unfinished story?

Authors:  Jeffrey J Hsu; Yin Tintut; Linda L Demer
Journal:  Cardiovasc Res       Date:  2021-07-07       Impact factor: 10.787

10.  EOS789, a broad-spectrum inhibitor of phosphate transport, is safe with an indication of efficacy in a phase 1b randomized crossover trial in hemodialysis patients.

Authors:  Kathleen M Hill Gallant; Elizabeth R Stremke; Laurie L Trevino; Ranjani N Moorthi; Simit Doshi; Meryl E Wastney; Nozomi Hisada; Jotaro Sato; Yoshitaka Ogita; Naohisa Fujii; Yuya Matsuda; Takei Kake; Sharon M Moe
Journal:  Kidney Int       Date:  2020-10-31       Impact factor: 10.612

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.